Briefing: Trump waives U.S. shipping law for 60 days to steady oil market
Strategic angle: The Trump administration aims to strengthen supply chains amid ongoing geopolitical tensions.
Editorial Staff Mar 18
All Articles
Browse the full archive, newest first.
Briefing: Iran war exposes BRICS fault lines
Strategic angle: As the Iran crisis widens, BRICS faces mounting pressure to respond — but internal rifts and competing interests are limiting the bloc's ability to act as a geopolitical actor.
Editorial Staff Mar 18
Briefing: Soaring Gas Prices Could Send Buyers Crawling Back To EVs And Hybrids
Strategic angle: Rising gas prices are making buyers rethink their aversion to EVs and hybrids, Bentley is cutting nearly 300 jobs due to tariffs and the EV rollback, and more.
Editorial Staff Mar 18
Briefing: A world‑first quantum battery charges faster when it gets bigger—but it's tiny and only lasts nanoseconds
Strategic angle: Imagine charging your phone almost instantly by exploiting the strange rules of quantum physics.
Editorial Staff Mar 18
Briefing: Rapid melting of Antarctic sea ice is largely driven by ocean warming, research reveals
Strategic angle: Research from the University of Gothenburg uncovers the factors behind the decline of Antarctic sea ice since 2015.
Editorial Staff Mar 18
Current price of oil as of March 16, 2026
Latest updates on oil prices from Fortune.
Editorial Staff Mar 18
Briefing: Why Guardant Health’s (GH) 2026 Screening Story Reinforced Piper Sandler’s Bullish View
Strategic angle: Piper Sandler maintains a positive outlook on Guardant Health following its 2026 screening developments.
Editorial Staff Mar 18
Briefing: Significant U.S. Uranium Deposit Advances with Permitting Team NUCL, CCJ, UEC, SMR, and NXE
Strategic angle: Uranium demand meets domestic supply urgency as key players advance permitting efforts.
Editorial Staff Mar 18
Briefing: Why TD Cowen Turned Bullish on Rivian Automotive (RIVN) Ahead of the R2 Launch
Strategic angle: TD Cowen expresses optimism for Rivian Automotive as it prepares for the R2 launch.
Editorial Staff Mar 18
Briefing: Why Ionis Pharmaceuticals’ (IONS) 2026 Catalyst Pipeline Supported Leerink’s Higher Target
Strategic angle: An analysis of Ionis Pharmaceuticals' upcoming catalysts and their impact on stock valuation.
Editorial Staff Mar 18